Ann: Opthea Granted Japanese Patent Covering OPT-302, page-2

Opthea Ltd. (OPT) reported the grant of Japanese patent covering both OPT-302 and compositions containing OPT-302 for use in treating disorders associated with aberrant angiogenesis and/or lymphangiogenesis, including eye diseases such are wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Patents covering Opthea's OPT-302 and extending out to 2034 have now been granted in Japan, the U.S.A., Australia, South Africa and Singapore and applications are pending in a further 14 countries

http://crweworld.com/article/news-provided-by-globenewswire/957450/opthea-granted-japanese-patent-covering-opt-302